Cobre Limited (ASX:CBE) Reports New Copper Intersection at Ngami Project
Cobre Limited (ASX:CBE) announces significant mineralisation findings at its Ngami Copper Project, enhancing exploration targets.
The Hub of Australian Finance News
Cobre Limited (ASX:CBE) announces significant mineralisation findings at its Ngami Copper Project, enhancing exploration targets.
Cynata Therapeutics Limited (ASX:CYP) has announced a trading halt pending a significant clinical trial update.
COSOL Limited enhances its data analytics capabilities with the acquisition of Toustone, aiming for growth in enterprise asset analytics.
Acrux Limited has received FDA approval for Nitroglycerin Ointment, expanding its portfolio in the topical market.
Pro Medicus co-founders Dr Sam Hupert and Mr Anthony Hall sell shares, reaffirming their commitment and retaining significant holdings.
Lycaon Resources Ltd launches maiden drilling at Stansmore, aiming for major mineral discoveries supported by government funding.
EQ Resources Ltd revises its funding strategy, opting out of the QIC loan for the Mt Carbine mine expansion while securing alternative funding arrangements.
Xamble Group Limited reports a strategic restructuring, closure of unprofitable operations, and positive outlook in Q3 2024 update.
Blackstone Minerals Limited completes its Entitlement Offer, securing significant funding for future growth initiatives.
Qube Holdings Limited has priced $600 million in senior unsecured notes, aiming to enhance liquidity and diversify its funding sources.